The researchers evaluated budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol in preventing COPD exacerbations and pneumonia hospitalizations in real-world settings.

A recent meta-analysis of seven studies showed that FP was more effective in the treatment of asthma than a two-fold higher dose of BUD. [13] This current study indicates that when FP is combined ...

Both budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol provide the guideline-recommended combination of inhaled corticosteroid-long acting muscarinic antagonist (LAMA ...

In a clinical guideline issued by the American College of Gastroenterology and published in the January issue of the American ...

Mean percentage predicted morning (a) and evening (b) peak expiratory flow rate (PEF) during 12 weeks of study treatment with a salmeterol/fluticasone propionate (FP) combination or budesonide in ...